365 related articles for article (PubMed ID: 21856357)
1. Immunization with recombinant Lactobacillus casei strains producing K99, K88 fimbrial protein protects mice against enterotoxigenic Escherichia coli.
Wen LJ; Hou XL; Wang GH; Yu LY; Wei XM; Liu JK; Liu Q; Wei CH
Vaccine; 2012 May; 30(22):3339-49. PubMed ID: 21856357
[TBL] [Abstract][Full Text] [Related]
2. Induction of immune responses in mice after oral immunization with recombinant Lactobacillus casei strains expressing enterotoxigenic Escherichia coli F41 fimbrial protein.
Liu JK; Hou XL; Wei CH; Yu LY; He XJ; Wang GH; Lee JS; Kim CJ
Appl Environ Microbiol; 2009 Jul; 75(13):4491-7. PubMed ID: 19447955
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity of 987P fimbriae of enterotoxigenic Escherichia coli surface-displayed on Lactobacillus casei.
Bai Y; Wang G; Qi H; Wang Y; Xu C; Yue L; Hou X; Yu L
Res Vet Sci; 2020 Feb; 128():308-314. PubMed ID: 31901569
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity and protective efficacy of orally or intranasally administered recombinant Lactobacillus casei expressing ETEC K99.
Wei CH; Liu JK; Hou XL; Yu LY; Lee JS; Kim CJ
Vaccine; 2010 May; 28(24):4113-8. PubMed ID: 19539580
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity of recombinant Lactobacillus casei-expressing F4 (K88) fimbrial adhesin FaeG in conjunction with a heat-labile enterotoxin A (LTAK63) and heat-labile enterotoxin B (LTB) of enterotoxigenic Escherichia coli as an oral adjuvant in mice.
Yu M; Qi R; Chen C; Yin J; Ma S; Shi W; Wu Y; Ge J; Jiang Y; Tang L; Xu Y; Li Y
J Appl Microbiol; 2017 Feb; 122(2):506-515. PubMed ID: 27860074
[TBL] [Abstract][Full Text] [Related]
6. Split immune response after oral vaccination of mice with recombinant Escherichia coli Nissle 1917 expressing fimbrial adhesin K88.
Remer KA; Bartrow M; Roeger B; Moll H; Sonnenborn U; Oelschlaeger TA
Int J Med Microbiol; 2009 Nov; 299(7):467-78. PubMed ID: 19467927
[TBL] [Abstract][Full Text] [Related]
7. [Comparison of immune response after oral and intranasal immunization with recombinant Lactobacillus casei expressing ETEC F41].
Liu J; Wei C; Hou X; Wang G; Yu L
Wei Sheng Wu Xue Bao; 2009 Apr; 49(4):524-30. PubMed ID: 19621642
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity of a fusion protein comprising coli surface antigen 3 and labile B subunit of enterotoxigenic Escherichia coli.
Alerasol M; Mousavi Gargari SL; Nazarian S; Bagheri S
Iran Biomed J; 2014; 18(4):212-218. PubMed ID: 25326019
[TBL] [Abstract][Full Text] [Related]
9. A tripartite fusion, FaeG-FedF-LT(192)A2:B, of enterotoxigenic Escherichia coli (ETEC) elicits antibodies that neutralize cholera toxin, inhibit adherence of K88 (F4) and F18 fimbriae, and protect pigs against K88ac/heat-labile toxin infection.
Ruan X; Liu M; Casey TA; Zhang W
Clin Vaccine Immunol; 2011 Oct; 18(10):1593-9. PubMed ID: 21813665
[TBL] [Abstract][Full Text] [Related]
10. Clinical trial to evaluate safety and immunogenicity of an oral inactivated enterotoxigenic Escherichia coli prototype vaccine containing CFA/I overexpressing bacteria and recombinantly produced LTB/CTB hybrid protein.
Lundgren A; Leach S; Tobias J; Carlin N; Gustafsson B; Jertborn M; Bourgeois L; Walker R; Holmgren J; Svennerholm AM
Vaccine; 2013 Feb; 31(8):1163-70. PubMed ID: 23306362
[TBL] [Abstract][Full Text] [Related]
11. Development and preclinical evaluation of safety and immunogenicity of an oral ETEC vaccine containing inactivated E. coli bacteria overexpressing colonization factors CFA/I, CS3, CS5 and CS6 combined with a hybrid LT/CT B subunit antigen, administered alone and together with dmLT adjuvant.
Holmgren J; Bourgeois L; Carlin N; Clements J; Gustafsson B; Lundgren A; Nygren E; Tobias J; Walker R; Svennerholm AM
Vaccine; 2013 May; 31(20):2457-64. PubMed ID: 23541621
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity and protective efficacy of a recombinant adenoviral based vaccine expressing heat-stable enterotoxin (STa) and K99 adhesion antigen of enterotoxigenic Escherichia coli in mice.
Deng G; Li W; Wu X; Bao S; Zeng J; Zhao N; Luo M; Liu X; Wang Y
Mol Immunol; 2015 Dec; 68(2 Pt C):684-91. PubMed ID: 26589454
[TBL] [Abstract][Full Text] [Related]
13. Attenuated Escherichia coli strains expressing the colonization factor antigen I (CFA/I) and a detoxified heat-labile enterotoxin (LThK63) enhance clearance of ETEC from the lungs of mice and protect mice from intestinal ETEC colonization and LT-induced fluid accumulation.
Byrd W; Boedeker EC
Vet Immunol Immunopathol; 2013 Mar; 152(1-2):57-67. PubMed ID: 23122616
[TBL] [Abstract][Full Text] [Related]
14. Maternal vaccination with a fimbrial tip adhesin and passive protection of neonatal mice against lethal human enterotoxigenic Escherichia coli challenge.
Luiz WB; Rodrigues JF; Crabb JH; Savarino SJ; Ferreira LC
Infect Immun; 2015 Dec; 83(12):4555-64. PubMed ID: 26371126
[TBL] [Abstract][Full Text] [Related]
15. Oral immunization with a Salmonella typhimurium vaccine vector expressing recombinant enterotoxigenic Escherichia coli K99 fimbriae elicits elevated antibody titers for protective immunity.
Ascón MA; Hone DM; Walters N; Pascual DW
Infect Immun; 1998 Nov; 66(11):5470-6. PubMed ID: 9784559
[TBL] [Abstract][Full Text] [Related]
16. Salmonella ghosts expressing enterotoxigenic Escherichia coli k88ab, k88ac, k99, and fasa fimbrial antigens induce robust immune responses in a mouse model.
Hur J; Kim CS; Eo SK; Park SY; Lee JH
Vet Q; 2015; 35(3):125-32. PubMed ID: 25853619
[TBL] [Abstract][Full Text] [Related]
17. Protection of mice against enterotoxigenic E. coli by immunization with a polyvalent enterotoxin comprising a combination of LTB, STa, and STb.
You J; Xu Y; He M; McAllister TA; Thacker PA; Li X; Wang T; Jin L
Appl Microbiol Biotechnol; 2011 Mar; 89(6):1885-93. PubMed ID: 21085949
[TBL] [Abstract][Full Text] [Related]
18. A Combination of Egg Yolk IgY and Phosvitin Inhibits the Growth of Enterotoxigenic Escherichia coli K88 and K99.
Gujral N; Yoo H; Bamdad F; Lee KY; Suh JW; Sunwoo H
Curr Pharm Biotechnol; 2017; 18(5):400-409. PubMed ID: 28443510
[TBL] [Abstract][Full Text] [Related]
19. Escherichia coli K88ac fimbriae expressing heat-labile and heat-stable (STa) toxin epitopes elicit antibodies that neutralize cholera toxin and STa toxin and inhibit adherence of K88ac fimbrial E. coli.
Zhang C; Zhang W
Clin Vaccine Immunol; 2010 Dec; 17(12):1859-67. PubMed ID: 20980482
[TBL] [Abstract][Full Text] [Related]
20. Enterotoxigenic Escherichia coli Adhesin-Toxoid Multiepitope Fusion Antigen CFA/I/II/IV-3xSTa
Nandre R; Ruan X; Lu T; Duan Q; Sack D; Zhang W
Infect Immun; 2018 Mar; 86(3):. PubMed ID: 29263112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
